k.pereira
TL2 Moderator · Kraków
Contributes reviews on supplier material. Based in Kraków.
Joined 13 March 2025 · last posted 2d
74 posts, newest first. Showing up to 150.
-
Semaglutide and alcohol: what is actually documented Replied, post #19 · Compounds › Semaglutide · 25 Jul 2026 · 0 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Immortal time bias in a claims-database study — one year on Replied, post #31 · Evidence › Study critique · 19 Jul 2026 · 2 likes When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you…
-
Deletion sequences: expected mass shifts by residue — the long version Replied, post #15 · Analytics › Impurities & related substances · 18 Jul 2026 · 0 likes On post #11 — agreed on the reasoning, with one qualification. Related substances: compounds chemically related to the target peptide but not the target peptide itself.…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #108 · Devices › Syringes & needles · 16 Jul 2026 · 23 likes Worth separating two things that post #104 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Journal club: what we got wrong in an earlier session Replied, post #82 · Evidence › Journal club · 14 Jul 2026 · 0 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Splitting an overlong document into two Replied, post #32 · Documentation › Wiki requests · 14 Jul 2026 · 15 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #99 · Analytics › HPLC & UHPLC · 2 Jul 2026 · 0 likes post #98 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #40 · Analytics › Impurities & related substances · 2 Jul 2026 · 4 likes Worth separating two things that post #36 runs together. Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common in…
-
Prescription requirements and telehealth models — a second dataset Replied, post #84 · Sourcing › Regulatory · 29 Jun 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Why chargeback is not the safety net people assume Replied, post #21 · Sourcing › Payments · 25 Jun 2026 · 24 likes Fraud and scams: if a supplier demands payment upfront with no recourse if delivery fails, you are taking a risk. Reputation and history of other buyers matter.
-
About the Receptor biology category Replied, post #5 · Pharmacology › Receptor biology · 21 Jun 2026 · 5 likes Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways over others) and can desensitise over time (responding less to the…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #27 · Compounds › Secretagogues & GH axis · 8 Jun 2026 · 13 likes IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a surrogate, with all the caveats that come with surrogates.…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #6 · marked as the solution · Compounds › Secretagogues & GH axis · 14 May 2026 · 13 likes Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for what they claim: less effect on cortisol and prolactin…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #36 · Compounds › Tirzepatide · 9 May 2026 · 0 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
What a certificate commits its issuer to — the long version Replied, post #5 · Analytics › COA interpretation · 6 May 2026 · 7 likes Picking up post #2: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #33 · Practice › Interactions · 27 Apr 2026 · 15 likes post #32 answers the question as asked. The question underneath it is different. Anticoagulants: no direct interaction with the compounds in this class. Weight loss and…
-
Choosing which test to pay for, given a fixed budget Replied, post #62 · Sourcing › Independent verification · 9 Apr 2026 · 0 likes On post #58 — agreed on the reasoning, with one qualification. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #15 · Compounds › Repair & healing peptides · 8 Mar 2026 · 21 likes This follows post #12 rather than contradicting it. BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #14 · Analytics › Impurities & related substances · 8 Mar 2026 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Choosing which test to pay for, given a fixed budget Replied, post #7 · Sourcing › Independent verification · 26 Feb 2026 · 13 likes post #6 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #75 · Outcomes › Progress reports · 17 Feb 2026 · 12 likes Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the rate tells you whether the change is steady,…
-
Dead volume across syringe and needle combinations Replied, post #70 · Devices › Syringes & needles · 11 Feb 2026 · 18 likes Worth separating two things that post #66 runs together. Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #34 · Practice › Storage & stability · 6 Feb 2026 · 14 likes post #33 is right about the mechanism and I think understates the practical bit. I want to gently push back on the reply above about storage extrapolation. The advice…
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #12 · Compounds › Secretagogues & GH axis · 6 Feb 2026 · 4 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Revisiting: Absolute versus relative contraindications Replied, post #17 · Safety › Contraindications · 1 Feb 2026 · 0 likes Severe renal impairment (eGFR
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #75 · Access › Pricing · 30 Jan 2026 · 10 likes Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose, vial volume, and whether you are using a vial or a pen.
-
Request: export my own posts — one year on Replied, post #23 · Meta › Feature requests · 17 Dec 2025 · 15 likes Alternatives: if you have thought of a way the current site might already serve your need, mention it. It helps assess whether the feature is truly missing or just not…
-
Tracking that stops updating and then resumes — the long version Replied, post #42 · Sourcing › Logistics · 23 Nov 2025 · 24 likes post #41 is right about the mechanism and I think understates the practical bit. Declaring contents accurately: declaring accurately reduces intervention risk. A…
-
Thyroid function tests during substantial weight change Replied, post #146 · Clinical › Bloodwork · 23 Nov 2025 · 1 like HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #52 · Compounds › Semaglutide · 21 Nov 2025 · 13 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Pen dose counters: what a click does and does not guarantee Replied, post #94 · Devices › Pens & autoinjectors · 18 Nov 2025 · 8 likes Visibility of the dose: some pens allow you to see the insulin remaining; others do not. Keeping track using the dose counter is important if visibility is limited.
-
[2026 update] What steady state means for the decision to escalate Replied, post #86 · Practice › Dosing & titration · 14 Nov 2025 · 16 likes post #85 is right about the mechanism and I think understates the practical bit. Micro-titration: the concept of increments smaller than the labelled steps. It has no…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #96 · Devices › Cold chain · 28 Oct 2025 · 0 likes On post #92 — agreed on the reasoning, with one qualification. Shipment during summer or to hot climates: consider shipping to a cold-storage facility rather than to…
-
Waist circumference technique and its repeatability Replied, post #9 · Outcomes › Progress reports · 22 Oct 2025 · 31 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #54 · Pharmacology › Receptor biology · 19 Oct 2025 · 16 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A preprint whose numbers changed substantially at publication Replied, post #60 · Evidence › Preprints · 20 Sep 2025 · 27 likes Coming back to post #58, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #47 · Analytics › Method validation · 13 Sep 2025 · 6 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Reading SURMOUNT-1 without the press release Replied, post #7 · Compounds › Tirzepatide · 12 Sep 2025 · 5 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #72 · Data & Tools › Datasets · 9 Sep 2025 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Cross-border purchase within the EU: the actual rules Replied, post #11 · Access › International · 26 Aug 2025 · 13 likes post #10 is right about the mechanism and I think understates the practical bit. Insurance and coverage: coverage decisions are national. A compound approved in one…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #102 · Compounds › Tirzepatide · 8 Aug 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #68 · Sourcing › Regulatory · 3 Aug 2025 · 8 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
System suitability injections: if they failed, the run did not happen Replied, post #17 · Analytics › HPLC & UHPLC · 25 Jul 2025 · 0 likes On post #13 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
EU-wide position versus national implementation Replied, post #16 · Regional › European Union · 7 Jul 2025 · 0 likes Spain: AEMPS is the regulator. Public reimbursement for weight management has been limited with regional variation in specialist pathways. Private prescription is common.
-
Repeatability versus intermediate precision Replied, post #132 · Analytics › Method validation · 3 Jul 2025 · 23 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #42 · Compounds › Repair & healing peptides · 17 Jun 2025 · 3 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
Half-life, steady state, and accumulation worked through Replied, post #21 · Pharmacology › Pharmacokinetics · 25 May 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Travel coolers and how long they really hold — the long version Replied, post #10 · Devices › Cold chain · 20 May 2025 · 0 likes Temperature excursions: brief excursions above 8 °C are tolerable for most compounds. Hours to a day at room temperature is usually acceptable. Days to weeks at room…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #32 · Compounds › Oral incretins · 15 May 2025 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Antibiotics and a course of something with delayed emptying Replied, post #31 · Practice › Interactions · 30 Apr 2025 · 10 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
A supplier that answers analytical questions with restated claims Replied, post #66 · Sourcing › Red flags · 28 Apr 2025 · 0 likes On post #62 — agreed on the reasoning, with one qualification. Safety documentation absent: a supplier that cannot provide information about sterility testing,…
-
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #10 · Evidence › Journal club · 24 Mar 2025 · 9 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #43 · Analytics › Mass spectrometry · 23 Mar 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Maintainer handover: how it works Replied, post #52 · Meta › Wiki maintenance · 17 Mar 2025 · 1 like post #51 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #106 · Pharmacology › Receptor biology · 16 Mar 2025 · 11 likes Long-term receptor changes: very little is known about what happens to receptor expression, signalling, and downstream effects over years of exposure to these…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #133 · Sourcing › Regulatory · 5 Mar 2025 · 23 likes Worth separating two things that post #129 runs together. Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds…
-
UK access routes, dated and sourced — a second dataset Replied, post #46 · Regional › UK & Ireland · 4 Mar 2025 · 30 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Validating a method you did not develop — does this still hold? Replied, post #23 · Analytics › Method validation · 19 Feb 2025 · 1 like Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #22 · Practice › Interactions · 7 Feb 2025 · 20 likes post #21 is right about the mechanism and I think understates the practical bit. Food interactions: most interactions are absorption interactions. Some medications…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #94 · Compounds › Semaglutide · 28 Jan 2025 · 30 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #20 · Evidence › Journal club · 31 Dec 2024 · 1 like SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #77 · Compounds › Semaglutide · 23 Dec 2024 · 3 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #9 · Evidence › Meta-analyses · 22 Dec 2024 · 0 likes On post #5 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Revisiting: Moderation log format change Replied, post #46 · Meta › Announcements · 29 Nov 2024 · 6 likes Picking up post #43: that is the part I would want checked first. Feedback to announcements: if you have feedback on an announced change (not a question, but your…
-
EMA product information as a primary source — does this still hold? Replied, post #21 · Regional › European Union · 15 Nov 2024 · 1 like Private prescription with self-payment is legal across the EU and is the common route where public reimbursement is not available.
-
Time to steady state after a dose increase Replied, post #138 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 3 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #24 · Clinical › Prescriber conversations · 2 Nov 2024 · 22 likes Preparing for an appointment: bring recent bloodwork, a list of current medications with doses and timing, and any questions written out. Written questions get better…
-
Gallbladder disease risk with rapid weight loss Replied, post #14 · Clinical › Comorbidities · 29 Sep 2024 · 23 likes post #13 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
When a red flag was a misunderstanding, and the retraction Replied, post #20 · Sourcing › Red flags · 21 Sep 2024 · 8 likes Picking up post #17: that is the part I would want checked first. Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because…
-
Promotion criteria, and the one that stops most nominations Replied, post #66 · Documentation › Doc review · 20 Sep 2024 · 0 likes Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the maintainer does not update, requesting withdrawal is appropriate.
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #15 · Clinical › Bloodwork · 7 Sep 2024 · 11 likes This follows post #12 rather than contradicting it. Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed…
-
Correlation in a self-tracked dataset: what it can support Replied, post #57 · Research Methods › Statistics · 22 Aug 2024 · 4 likes post #56 is right about the mechanism and I think understates the practical bit. Number needed to treat: how many people need to be treated to prevent one bad outcome…
-
Guidelines revision: what changed and why Replied, post #50 · Meta › Announcements · 26 Jul 2024 · 2 likes Picking up post #47: that is the part I would want checked first. Archives: older announcements are archived by date. Checking archives is useful if you want to know…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #87 · Practice › Dosing & titration · 9 Jul 2024 · 17 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…